Medical Information

To ensure medication safety, two absolute contraindications must be identified before using Delgocitinib ointment: those with active infections in the external application site and those who are allergic to any ingredients of this product. The following are specific details.

1. Active infection of external parts

1.1 Clear prohibition: If there are active infections caused by bacteria, viruses (such as herpes simplex, chickenpox), fungi, or parasites in the skin area where the drug is intended to be used, the use of this drug is prohibited.

1.2 Signs of infection: The presence of pus, blister rupture, painful erythema, yellow scabs, or persistent exudate at the medication site suggests the possibility of infection.

1.3 Treatment principle: The doctor should first treat the infection and evaluate whether to use this medication after the infection is completely controlled.

2. Allergic reactions to this product

2.1 Absolute contraindications: Those who have previously been allergic to Delgocitinib or any excipients in the ointment (such as matrix, preservatives, etc.) are prohibited from using it.

2.2 Common allergy symptoms: including severe itching, diffuse erythema, urticaria (wheals), increased skin swelling or burning sensation that occur rapidly after medication.

2.3 Serious allergy signals: If there is swelling in the face/lips, difficulty breathing, or tightness in the throat, immediate cessation of use and emergency medical attention should be sought.

3. Other precautions

3.1 Vaccination: It is not recommended to receive attenuated live vaccines at the site of administration during medication. Please inform your doctor in advance of your medication status.

3.2 Pregnancy and lactation: Pregnant and lactating women should use medication with caution after a thorough evaluation by a doctor and should not self medicate.